1. Travis WD, Rush W, Flieder DB, et al. Survival analysis of 200 pulmonary neuroendocrine tumors with clarification of criteria for atypical carcinoid and its separation from typical carcinoid. Am J Surg Pathol. Aug 1998;22(8):934-44. doi:10.1097/00000478-199808000-00003
  2. Houston KA, Henley SJ, Li J, White MC, Richards TB. Patterns in lung cancer incidence rates and trends by histologic type in the United States, 2004-2009. Lung Cancer. Oct 2014;86(1):22-8. doi:10.1016/j.lungcan.2014.08.001
  3. Zeng Q, Vogtmann E, Jia MM, et al. Tobacco smoking and trends in histological subtypes of female lung cancer at the Cancer Hospital of the Chinese Academy of Medical Sciences over 13 years. Thorac Cancer. Aug 2019;10(8):1717-1724. doi:10.1111/1759-7714.13141
  4. Antony GK, Bertino E, Franklin M, Otterson GA, Dudek AZ. Small cell lung cancer in never smokers: report of two cases. J Thorac Oncol. May 2010;5(5):747-8. doi:10.1097/JTO.0b013e3181d6e124
  5. Varghese AM, Zakowski MF, Yu HA, et al. Small-cell lung cancers in patients who never smoked cigarettes. J Thorac Oncol. Jun 2014;9(6):892-6. doi:10.1097/JTO.0000000000000142
  6. Nicholson AG, Chansky K, Crowley J, et al. The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for the Revision of the Clinical and Pathologic Staging of Small Cell Lung Cancer in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer. J Thorac Oncol. Mar 2016;11(3):300-11. doi:10.1016/j.jtho.2015.10.008
  7. Miller CW, Simon K, Aslo A, et al. p53 mutations in human lung tumors. Cancer Res. Apr 1 1992;52(7):1695-8.
  8. Takahashi T, Takahashi T, Suzuki H, et al. The p53 gene is very frequently mutated in small-cell lung cancer with a distinct nucleotide substitution pattern. Oncogene. Oct 1991;6(10):1775-8.
  9. Peifer M, Fernandez-Cuesta L, Sos ML, et al. Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer. Nat Genet. Oct 2012;44(10):1104-10. doi:10.1038/ng.2396
  10. Gaspar LE, McNamara EJ, Gay EG, et al. Small-cell lung cancer: prognostic factors and changing treatment over 15 years. Clin Lung Cancer. Mar 2012;13(2):115-22. doi:10.1016/j.cllc.2011.05.008
  11. Faivre-Finn C, Snee M, Ashcroft L, et al. Concurrent once-daily versus twice-daily chemoradiotherapy in patients with limited-stage small-cell lung cancer (CONVERT): an open-label, phase 3, randomised, superiority trial. Lancet Oncol. Aug 2017;18(8):1116-1125. doi:10.1016/S1470-2045(17)30318-2
  12. De Ruysscher D, Pijls-Johannesma M, Bentzen SM, et al. Time between the first day of chemotherapy and the last day of chest radiation is the most important predictor of survival in limited-disease small-cell lung cancer. J Clin Oncol. Mar 1 2006;24(7):1057-63. doi:10.1200/JCO.2005.02.9793
  13. Jain D, Allen TC, Aisner DL, et al. Rapid On-Site Evaluation of Endobronchial Ultrasound-Guided Transbronchial Needle Aspirations for the Diagnosis of Lung Cancer: A Perspective From Members of the Pulmonary Pathology Society. Arch Pathol Lab Med. Feb 2018;142(2):253-262. doi:10.5858/arpa.2017-0114-SA
  14. Ye T, Hu H, Luo X, Chen H. The role of endobronchial ultrasound guided transbronchial needle aspiration (EBUS-TBNA) for qualitative diagnosis of mediastinal and hilar lymphadenopathy: a prospective analysis. BMC Cancer. Mar 21 2011;11:100. doi:10.1186/1471-2407-11-100
  15. Lee BE, Kletsman E, Rutledge JR, Korst RJ. Utility of endobronchial ultrasound-guided mediastinal lymph node biopsy in patients with non-small cell lung cancer. J Thorac Cardiovasc Surg. Mar 2012;143(3):585-90. doi:10.1016/j.jtcvs.2011.11.022
  16. Cerfolio RJ, Bryant AS, Eloubeidi MA, et al. The true false negative rates of esophageal and endobronchial ultrasound in the staging of mediastinal lymph nodes in patients with non-small cell lung cancer. Ann Thorac Surg. Aug 2010;90(2):427-34. doi:10.1016/j.athoracsur.2010.04.062
  17. Mehta HJ, Tanner NT, Silvestri G, et al. Outcome of patients with negative and unsatisfactory cytologic specimens obtained by endobronchial ultrasound-guided transbronchial fine-needle aspiration of mediastinal lymph nodes. Cancer Cytopathol. Feb 2015;123(2):92-7. doi:10.1002/cncy.21482
  18. Haack H, Johnson LA, Fry CJ, et al. Diagnosis of NUT midline carcinoma using a NUT-specific monoclonal antibody. Am J Surg Pathol. Jul 2009;33(7):984-91. doi:10.1097/PAS.0b013e318198d666